Inhaled mannitol improves lung function assessed by forced oscillation in a placebo controlled trial in patients with bronchiectasis

M. D. Goldman, E. Daviskas, J. A. Turton, S. D. Anderson (Los Angeles, United States Of America; Sydney, Australia)

Source: Annual Congress 2004 - Noninvasive approaches to measure airway epithelial cell function
Session: Noninvasive approaches to measure airway epithelial cell function
Session type: Poster Discussion
Number: 2943
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. D. Goldman, E. Daviskas, J. A. Turton, S. D. Anderson (Los Angeles, United States Of America; Sydney, Australia). Inhaled mannitol improves lung function assessed by forced oscillation in a placebo controlled trial in patients with bronchiectasis. Eur Respir J 2004; 24: Suppl. 48, 2943

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Improvement of lung function after a 6-week placebo controlled budesonide treatment in symptomatic infants with decreased airways conductance
Source: Eur Respir J 2004; 24: Suppl. 48, 157s
Year: 2004

Double blind, placebo controlled crossover study in COPD patients to assess the acute effect of budesonide/formoterol using HRCT and lung function tests
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


Effect of inhaled vaporized cannabis on dynamic airway function, breathlessness and exercise intolerance in adults with advanced COPD: A randomized controlled trial
Source: International Congress 2018 – New methods and concepts in tests of lung and respiratory muscle function
Year: 2018

A randomised double-blind placebo-controlled trial of the effect of inhaled heparin on lung function, hyperinflation and exercise capacity in patients with COPD
Source: International Congress 2016 – Novel insights into the treatment of COPD
Year: 2016

Inhaled corticosteroids in patients with mild to moderate COPD with and without airway hyperresponsiveness to mannitol: A randomized placebo controlled trial
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


A placebo controlled trial with inhaled mannitol improves health related quality of life in patients with bronchiectasis
Source: Annual Congress 2004 - Bronchiectasis
Year: 2004


A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo
Source: Eur Respir J 2006; 28: Suppl. 50, 764s
Year: 2006

Acute effects of combined exercise and oscillatory positive expiratory pressure therapy on sputum properties and lung diffusing capacity in cystic fibrosis: a randomized, controlled, crossover trial
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018



Noninvasive ventilation compared to Albuterol in respiratory mechanics and lung function of asthmatics after bronchoprovocation. Randomized cross-over trial.
Source: International Congress 2018 – New tools for managing respiratory failure
Year: 2018

Randomized controlled trial of nebulized budesonide suspension in acute severe exacerbation of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 244s
Year: 2002

Ciclesonide significantly improves pulmonary function when compared with budesonide: a randomized 12-week study
Source: Eur Respir J 2003; 22: Suppl. 45, 411s
Year: 2003

The effects of a crossover treatment with inhaled corticosteroids and N-acetylcysteine on lung function parameters in COPD-patients
Source: Eur Respir J 2004; 24: Suppl. 48, 342s
Year: 2004

A single-dose double-blind study comparing efficacy of two dry powder inhalers containing budesonide and formoterol in asthmatic patients
Source: International Congress 2016 – Asthma management
Year: 2016


The effect of montelukast added to steroid on airway function as compared with steroid alone and placebo: a single blind, controlled study in acute asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 263s
Year: 2001

Once-daily tiotropium Respimat add-on therapy improves lung function in children with moderate symptomatic asthma, independent of the degree of airflow obstruction
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017


Once-daily QVA149 provides superior improvements in lung function compared with glycopyrronium and tiotropium in severe COPD patients: A 52 week pooled analysis
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013

Transition to extra-fine formulation of inhaled beclomethasone/formoterol improves clinical and functional parameters in controlled and partly controlled asthmatics
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II
Year: 2010


Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study
Source: Eur Respir J 2002; 20: 1138-1146
Year: 2002



A new class of bronchodilator improves lung function in COPD: a trial with GSK961081
Source: Eur Respir J 2013; 42: 972-981
Year: 2013



Normal lung function and absence of bronchodilator response in children with stable, controlled asthma using inhaled corticosteroids
Source: Annual Congress 2006 - New features of paediatric asthma
Year: 2006